Niemann-Pick Disease Type B: Clinical Trials

1 trial for Niemann-Pick Disease Type B, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Niemann-Pick Disease Type B: new trials by email Literature Review of Niemann-Pick Disease Type B trials Research Report on Niemann-Pick Disease Type B

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Stem Cell Transplantation, Cyclophosphamide, Campath-1H - Hurler's Syndrome, Maroteaux-Lamy Syndrome
Phase 2TerminatedMasonic Cancer Center, University of Minnesota182008-03-012017-12-28

Narrower conditions

Aspartylglucosaminuria (1)  ·  Fucosidosis (1)  ·  Leukodystrophy, Globoid Cell (1)  ·  Leukodystrophy, Metachromatic (1)  ·  Metabolism, Inborn Errors (1)  ·  Mucopolysaccharidosis I (1)  ·  Mucopolysaccharidosis VI (1)  ·  Mucopolysaccharidosis VII (1)  ·  Niemann-Pick Disease, Type B (1)  ·  Niemann-Pick Disease, Type C (1)  ·  Peroxisomal Disorders (1)  ·  Sphingolipidoses (1)  ·  Wolman Disease (1)  ·  alpha-Mannosidosis (1)

Broader conditions

Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Carbohydrate Metabolism, Inborn Errors (1)  ·  Central Nervous System Diseases (1)  ·  Cholesterol Ester Storage Disease (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Demyelinating Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hereditary Central Nervous System Demyelinating Diseases (1)  ·  Histiocytosis (1)  ·  Histiocytosis, Non-Langerhans-Cell (1)  ·  Infant, Newborn, Diseases (1)

Interventions

Alemtuzumab (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Cyclophosphamide (1)  ·  Stem Cell Transplantation (1)

Sponsors

Masonic Cancer Center, University of Minnesota (1)

Countries

United States (1)

Top investigators

Paul Orchard, MD (1)

Results publications

PMID 21586746